ArticleOpen forum infectious diseases2026
Comparable Norovirus Shedding in Symptomatic and Asymptomatic Individuals: A Hospital-Based Study in Bangladesh.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Background: The frequent detection of norovirus in the stool of healthy people may be due to prolonged norovirus shedding after recovery from illness or asymptomatic infections. We describe norovirus shedding patterns in symptomatic and asymptomatic persons in Bangladesh. Method: We enrolled acute gastroenteritis (AGE) cases and non-AGE controls from 2 hospitals from January to September, 2023. Fecal samples were tested for norovirus by rapid antigen testing and confirmed by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Positive persons were retested at days 20, 40, 60, and 120 by RT-qPCR. Shedding duration was calculated as the number of days from enrollment to the midpoint between the last norovirus-positive and first norovirus-negative specimens. Cycle threshold (Ct) values served as an inverse proxy for the viral load. Results: Among 16 persons confirmed infected with norovirus (11/32 AGE cases; 5/28 non-AGE controls), a total of 74 stool samples were collected from enrollment through follow-up, of which 28 (38%) were norovirus positive. Of these, 20 (71%) were typed as GII.4 Sydney[P16], 1 as GII.3[P16], and 7 as GII untypeable. The median duration of norovirus shedding was similar between AGE cases (10 days, interquartile range [IQR], 9.5-29 days) and asymptomatic controls (9.5 days, IQR, 9.5-49 days). Norovirus Ct values varied substantially between persons and overlapped significantly among AGE cases and non-AGE controls. Conclusions: Norovirus shedding quantity and duration were similar between AGE cases and asymptomatic controls, complicating the attribution of norovirus infection to AGE in Bangladesh. Larger longitudinal studies would more accurately characterize norovirus shedding in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.